[IMCAS Asia 2026 Special ⑲ | Interview] "Not Rejuvenation, But Prejuvenation" — Robert Fielitz, SVP and Managing Director, Global Distributor Operations, Candela

 A shift is underway in aesthetic medicine — from slowing aging to reversing its visible signs. At IMCAS Asia 2026 in Bangkok, we sat down with Robert Fielitz, Candela's SVP and Managing Director, Global Distributor Operations. A long-established global manufacturer of energy-based devices (EBDs), Candela put this very idea front and center with its symposium theme, "Turning Back The Skin Clock." Fielitz described the company's portfolio — Vbeam, PicoWay and Matrix RF — as united by a single goal: helping patients look more like they did years earlier. He linked this to the three principles that have sustained Candela for more than half a century — science, results and trust — and, on the flagship PicoWay platform, pointed to the 730 nm handpiece's 250 ps pulse duration, its photoacoustic and photomechanical effects, and a non-ablative fractional resurfacing approach designed to preserve epidermal integrity. He also shared why he sees Asia as the world's fastest-growing market, how demand is expanding among Gen Z consumers and men as the field shifts from rejuvenation to prejuvenation, and why Korean medical aesthetics could become a formidable global competitor once it moves beyond "me-too" products toward research-driven innovation. 

#MedicalAestheticNews #Candela #IMCASAsia2026

★ Article Link: https://www.medicalaestheticnews.com/news/articleView.html?idxno=20121